L. Daniel Browne, CEO and President at Revance Therapeutics, Inc. (RVNC), bought 6,000 shares at $16.67 ($100K) on 2014-11-28, disclosed to the SEC on 2014-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| RVNC | SELL | 2018-03-16 | $376K | — | Filing → |
| RVNC | SELL | 2018-03-09 | $1.7M | — | Filing → |
| RVNC | SELL | 2017-11-24 | $190K | — | Filing → |